表紙
市場調査レポート

薬物依存症:世界の治験レビュー

Drug Addiction Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 306662
出版日 ページ情報 英文 76 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
薬物依存症:世界の治験レビュー Drug Addiction Global Clinical Trials Review, H1, 2014
出版日: 2014年06月20日 ページ情報: 英文 76 Pages
概要

当レポートでは、薬物依存症に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、地域フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 薬物依存症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:中枢神経系疾患の治験件数に対する薬物依存症の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7(新興7ヶ国)諸国での治験件数:中枢神経系疾患の治験件数に対する薬物依存症の治験件数比率

E7(新興7ヶ国)諸国での治験件数:フェーズ(相)別

E7(新興7ヶ国)諸国での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

薬物依存症における最新の治験情報

治験のプロファイル

  • 代表的企業の治験の概要
    • RTI International
    • Johnson & Johnson
    • Alkermes Inc. (Inactive)
    • SK Holdings Co., Ltd.
    • Reckitt Benckiser Group Plc
    • GlaxoSmithKline plc
    • Embera NeuroTherapeutics, Inc.
    • Catalyst Pharmaceutical Partners, Inc.
    • Gilead Sciences, Inc.
    • D&A Pharma SAS
  • 代表的な研究機関・病院の治験の概要
    • National Institute on Drug Abuse
    • Yale University
    • University of Pennsylvania
    • New York State Psychiatric Institute
    • University of California, Los Angeles
    • Johns Hopkins University
    • Medical University of South Carolina
    • Baylor College of Medicine
    • University of Arkansas
    • University of Kentucky

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GDHC2213CTIDB

GlobalData's clinical trial report, "Drug Addiction Global Clinical Trials Review, H1, 2014" provides data on the Drug Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Drug Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Drug Addiction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Drug Addiction
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Drug Addiction to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Drug Addiction to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Drug Addiction
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Drug Addiction Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Drug Addiction
    • May 27, 2014: Biotie: nepicastat study in cocaine dependence completes enrollment ahead of schedule - top-line data expected around end 2014
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • RTI International
      • Clinical Trial Overview of RTI International
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Alkermes Inc. (Inactive)
      • Clinical Trial Overview of Alkermes Inc. (Inactive)
      • SK Holdings Co., Ltd.
      • Clinical Trial Overview of SK Holdings Co., Ltd.
      • Reckitt Benckiser Group Plc
      • Clinical Trial Overview of Reckitt Benckiser Group Plc
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Embera NeuroTherapeutics, Inc.
      • Clinical Trial Overview of Embera NeuroTherapeutics, Inc.
      • Catalyst Pharmaceutical Partners, Inc.
      • Clinical Trial Overview of Catalyst Pharmaceutical Partners, Inc.
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • D&A Pharma SAS
      • Clinical Trial Overview of D&A Pharma SAS
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute on Drug Abuse
      • Clinical Trial Overview of National Institute on Drug Abuse
      • Yale University
      • Clinical Trial Overview of Yale University
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • New York State Psychiatric Institute
      • Clinical Trial Overview of New York State Psychiatric Institute
      • University of California, Los Angeles
      • Clinical Trial Overview of University of California, Los Angeles
      • Johns Hopkins University
      • Clinical Trial Overview of Johns Hopkins University
      • Medical University of South Carolina
      • Clinical Trial Overview of Medical University of South Carolina
      • Baylor College of Medicine
      • Clinical Trial Overview of Baylor College of Medicine
      • University of Arkansas
      • Clinical Trial Overview of University of Arkansas
      • University of Kentucky
      • Clinical Trial Overview of University of Kentucky
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Drug Addiction Therapeutics, Global, Clinical Trials by Region, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Drug Addiction Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Drug Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Drug Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Drug Addiction Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Drug Addiction Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Drug Addiction Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Drug Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by RTI International, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Alkermes Inc. (Inactive), 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by SK Holdings Co., Ltd., 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Reckitt Benckiser Group Plc, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Embera NeuroTherapeutics, Inc., 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Catalyst Pharmaceutical Partners, Inc., 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by D&A Pharma SAS, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Drug Abuse, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Arkansas, 2014*
  • Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2014*

List of Figures

  • Drug Addiction Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Drug Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Drug Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Drug Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Drug Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Drug Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Drug Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Drug Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Drug Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top